Alan Weiss1, Salam Hussain2,3, Bradley Ng4, Shanthi Sarma5, John Tiller6,7, Susan Waite8,9, Colleen Loo10,11. 1. 1 School of Medicine and Public Health, Faculty of Health and Medicine, The University of Newcastle, Australia, Callaghan, NSW, Australia. 2. 2 School of Psychiatry, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, WA, Australia. 3. 3 Sir Charles Gairdner Hospital Mental Health Service, Perth, WA, Australia. 4. 4 Mental Health and Specialist Services, Robina Hospital, Robina, QLD, Australia. 5. 5 Mental Health and Specialist Services, Gold Coast Hospital and Health Service, Southport, QLD, Australia. 6. 6 Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia. 7. 7 Professorial Psychiatry Unit, Albert Road Clinic, Melbourne, VIC, Australia. 8. 8 Department of Mental Health Services, The Queen Elizabeth Hospital, Adelaide, SA, Australia. 9. 9 Discipline of Psychiatry, The University of Adelaide, Adelaide, SA, Australia. 10. 10 School of Psychiatry, UNSW Sydney, Sydney, NSW, Australia. 11. 11 Sydney Neurostimulation Centre, Black Dog Institute, Randwick, NSW, Australia.
Abstract
OBJECTIVES: To provide guidance for the optimal administration of electroconvulsive therapy, in particular maintaining the high efficacy of electroconvulsive therapy while minimising cognitive side-effects, based on scientific evidence and supplemented by expert clinical consensus. METHODS: Articles and information were sourced from existing guidelines and the published literature. Information was revised and discussed by members of the working group of the Royal Australian and New Zealand College of Psychiatrists' Section for Electroconvulsive Therapy and Neurostimulation, and findings were then formulated into consensus-based recommendations and guidance. The guidelines were subjected to rigorous successive consultation and external review within the Royal Australian and New Zealand College of Psychiatrists, involving the full Section for Electroconvulsive Therapy and Neurostimulation membership, and expert and clinical advisors and professional bodies with an interest in electroconvulsive therapy administration. RESULTS: The Royal Australian and New Zealand College of Psychiatrists' professional practice guidelines for the administration of electroconvulsive therapy provide up-to-date advice regarding the use of electroconvulsive therapy in clinical practice and are informed by evidence and clinical experience. The guidelines are intended for use by psychiatrists and also others with an interest in the administration of electroconvulsive therapy. The guidelines are not intended as a directive about clinical practice or instructions as to what must be done for a given patient, but provide guidance to facilitate best practice to help optimise outcomes for patients. The outcome is guidelines that strive to find the appropriate balance between promoting best evidence-based practice and acknowledging that electroconvulsive therapy is a continually evolving practice. CONCLUSION: The guidelines provide up-to-date advice for psychiatrists to promote optimal standards of electroconvulsive therapy practice.
OBJECTIVES: To provide guidance for the optimal administration of electroconvulsive therapy, in particular maintaining the high efficacy of electroconvulsive therapy while minimising cognitive side-effects, based on scientific evidence and supplemented by expert clinical consensus. METHODS: Articles and information were sourced from existing guidelines and the published literature. Information was revised and discussed by members of the working group of the Royal Australian and New Zealand College of Psychiatrists' Section for Electroconvulsive Therapy and Neurostimulation, and findings were then formulated into consensus-based recommendations and guidance. The guidelines were subjected to rigorous successive consultation and external review within the Royal Australian and New Zealand College of Psychiatrists, involving the full Section for Electroconvulsive Therapy and Neurostimulation membership, and expert and clinical advisors and professional bodies with an interest in electroconvulsive therapy administration. RESULTS: The Royal Australian and New Zealand College of Psychiatrists' professional practice guidelines for the administration of electroconvulsive therapy provide up-to-date advice regarding the use of electroconvulsive therapy in clinical practice and are informed by evidence and clinical experience. The guidelines are intended for use by psychiatrists and also others with an interest in the administration of electroconvulsive therapy. The guidelines are not intended as a directive about clinical practice or instructions as to what must be done for a given patient, but provide guidance to facilitate best practice to help optimise outcomes for patients. The outcome is guidelines that strive to find the appropriate balance between promoting best evidence-based practice and acknowledging that electroconvulsive therapy is a continually evolving practice. CONCLUSION: The guidelines provide up-to-date advice for psychiatrists to promote optimal standards of electroconvulsive therapy practice.
Authors: Takahiro Soda; Declan M McLoughlin; Scott R Clark; Leif Oltedal; Ute Kessler; Jan Haavik; Chad Bousman; Daniel J Smith; Miquel Bioque; Caitlin C Clements; Colleen Loo; Fidel Vila-Rodriguez; Alessandra Minelli; Brian J Mickey; Roumen Milev; Anna R Docherty; Julie Langan Martin; Eric D Achtyes; Volker Arolt; Ronny Redlich; Udo Dannlowski; Narcis Cardoner; Emily Clare; Nick Craddock; Arianna Di Florio; Monika Dmitrzak-Weglarz; Liz Forty; Katherine Gordon-Smith; Mustafa Husain; Wendy M Ingram; Lisa Jones; Ian Jones; Mario Juruena; George Kirov; Mikael Landén; Daniel J Müller; Axel Nordensköld; Erik Pålsson; Meethu Paul; Agnieszka Permoda; Bartlomiej Pliszka; Jamie Rea; Klaus O Schubert; Joshua A Sonnen; Virginia Soria; Will Stageman; Akihiro Takamiya; Mikel Urretavizacaya; Stuart Watson; Maxim Zavorotny; Allan H Young; Eduard Vieta; Janusz K Rybakowski; Massimo Gennarelli; Peter P Zandi; Patrick F Sullivan; Bernhard T Baune Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-12-04 Impact factor: 5.270
Authors: Harold A Sackeim; Joan Prudic; D P Devanand; Mitchell S Nobler; Roger F Haskett; Benoit H Mulsant; Peter B Rosenquist; William V McCall Journal: Brain Stimul Date: 2020-06-22 Impact factor: 8.955
Authors: James Luccarelli; Thomas H McCoy; Mai Uchida; Allison Green; Stephen J Seiner; Michael E Henry Journal: J Child Adolesc Psychopharmacol Date: 2021-10-06 Impact factor: 3.031
Authors: Gregory L Sahlem; William V McCall; E Baron Short; Peter B Rosenquist; James B Fox; Nagy A Youssef; Andrew J Manett; Suzanne E Kerns; Morgan M Dancy; Laryssa McCloud; Mark S George; Harold A Sackeim Journal: Brain Stimul Date: 2020-07-29 Impact factor: 8.955
Authors: Nagy A Youssef; Mark S George; William V McCall; Gregory L Sahlem; Baron Short; Suzanne Kerns; Andrew J Manett; James B Fox; Morgan Dancy; Daniel Cook; William Devries; Peter B Rosenquist; Harold A Sackeim Journal: J ECT Date: 2021-12-01 Impact factor: 3.692
Authors: Anna Z Antosik-Wójcińska; Monika Dominiak; Paweł Mierzejewski; Piotr Jażdżyk; Gabor Gazdag; Rozalia Takacs; Adam Wichniak Journal: Neuropsychiatr Dis Treat Date: 2021-02-22 Impact factor: 2.570
Authors: A Amad; M Magnat; C Quilès; A Yrondi; A Sauvaget; S Bulteau; M Plaze; M Rotharmel; M Polosan; D Lévy-Chavagnat; N Jaafari; G Vaiva; P Thomas Journal: Encephale Date: 2020-04-22 Impact factor: 1.291